Federated Hermes’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.88M Buy
42,743
+29,962
+234% +$4.12M 0.01% 691
2025
Q1
$2.3M Sell
12,781
-267
-2% -$48.1K 0.01% 903
2024
Q4
$2.04M Buy
13,048
+229
+2% +$35.9K ﹤0.01% 927
2024
Q3
$2.33M Buy
+12,819
New +$2.33M 0.01% 898
2023
Q4
Sell
-5
Closed -$580 2121
2023
Q3
$580 Hold
5
﹤0.01% 2034
2023
Q2
$587 Hold
5
﹤0.01% 2047
2023
Q1
$400 Sell
5
-1
-17% -$80 ﹤0.01% 2084
2022
Q4
$475 Hold
6
﹤0.01% 2086
2022
Q3
$1K Hold
6
﹤0.01% 2051
2022
Q2
$1K Hold
6
﹤0.01% 2050
2022
Q1
$1K Sell
6
-654
-99% -$109K ﹤0.01% 2097
2021
Q4
$46K Sell
660
-7,451
-92% -$519K ﹤0.01% 1798
2021
Q3
$423K Sell
8,111
-145,503
-95% -$7.59M ﹤0.01% 1542
2021
Q2
$10.4M Buy
153,614
+19,623
+15% +$1.33M 0.02% 642
2021
Q1
$10.3M Buy
+133,991
New +$10.3M 0.02% 652
2019
Q2
Sell
-124
Closed -$4K 2191
2019
Q1
$4K Sell
124
-834
-87% -$26.9K ﹤0.01% 1999
2018
Q4
$20K Hold
958
﹤0.01% 1770
2018
Q3
$17K Buy
+958
New +$17K ﹤0.01% 1867